Trial site
Groupe Hospitalier Du Havre
- 15running trials
- 3closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- COPD5 trials
- Multiple myeloma2 trials
- Rheumatoid arthritis2 trials
- Ankylosing spondylitis1 trial
- Asthma1 trial
- Bronchiectasis1 trial
- Colorectal cancer1 trial
- Cystic fibrosis1 trial
- Endometrial cancer1 trial
- High blood pressure1 trial
- Iron deficiency anaemia1 trial
- Psoriasis1 trial
- and 4 more
- Phase
- Phase 37 trials
- Phase 44 trials
- Phase 22 trials
- Status
- Recruiting10 trials
- Not yet recruiting5 trials
- Completed1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris3 trials
- Groupe Hospitalier du Havre3 trials
- University Hospital, Rouen2 trials
- University Hospital, Strasbourg, France2 trials
- ADIR Association1 trial
- and 7 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
OBINUSS - A trial to evaluate a new drug in systemic sclerosis: obinutuzumab.
Not yet recruiting
Recruiting
SPARK: Supporting Physical Activity Through Reality-Augmented Knowledge in COPD
Recruiting
COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities
Recruiting
Recruiting
Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD3 recruiting
- Multiple myeloma2 recruiting
- Rheumatoid arthritis2 recruiting
- Ankylosing spondylitis1 recruiting
- Asthma1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- High blood pressure1 recruiting
- Iron deficiency anaemia1 recruiting
- Psoriasis1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Sickle cell disease1 recruiting
- Stroke1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026